Applied Therapeutics (APLT) Competitors

Aerovate Therapeutics (NASDAQ:AVTE) and Applied Therapeutics (NASDAQ:APLT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, community ranking, media sentiment, risk, profitability and institutional ownership.

Do insiders & institutionals have more ownership in AVTE or APLT?

98.3% of Applied Therapeutics shares are held by institutional investors. 24.9% of Aerovate Therapeutics shares are held by company insiders. Comparatively, 1.6% of Applied Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community favor AVTE or APLT?

Applied Therapeutics received 61 more outperform votes than Aerovate Therapeutics when rated by MarketBeat users. Likewise, 56.74% of users gave Applied Therapeutics an outperform vote while only 54.29% of users gave Aerovate Therapeutics an outperform vote.

Company	Underperform	Outperform
Aerovate Therapeutics	Outperform Votes 19 54.29%	Underperform Votes 16 45.71%
Applied Therapeutics	Outperform Votes 80 56.74%	Underperform Votes 61 43.26%

Does the media favor AVTE or APLT?

In the previous week, Applied Therapeutics had 1 more articles in the media than Aerovate Therapeutics. MarketBeat recorded 2 mentions for Applied Therapeutics and 1 mentions for Aerovate Therapeutics. Aerovate Therapeutics' average media sentiment score of 1.61 beat Applied Therapeutics' score of 0.98 indicating that Aerovate Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aerovate Therapeutics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Applied Therapeutics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, AVTE or APLT?

Aerovate Therapeutics has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Applied Therapeutics has a beta of 1.86, indicating that its stock price is 86% more volatile than the S&P 500.

Do analysts rate AVTE or APLT?

Aerovate Therapeutics currently has a consensus price target of $78.75, suggesting a potential upside of 1,020.20%. Applied Therapeutics has a consensus price target of $6.10, suggesting a potential upside of 1,571.23%. Given Applied Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Applied Therapeutics is more favorable than Aerovate Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aerovate Therapeutics	0 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Applied Therapeutics	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Is AVTE or APLT more profitable?

Aerovate Therapeutics' return on equity of -90.19% beat Applied Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aerovate Therapeutics	N/A	-90.19%	-77.47%
Applied Therapeutics	N/A	-260.75%	-76.04%

Which has higher earnings and valuation, AVTE or APLT?

Aerovate Therapeutics has higher earnings, but lower revenue than Applied Therapeutics. Aerovate Therapeutics is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aerovate Therapeutics	N/A	N/A	-$75.52M	-$1.70	-4.14
Applied Therapeutics	$265K	195.00	-$119.76M	-$0.43	-0.85

Summary

Applied Therapeutics beats Aerovate Therapeutics on 12 of the 16 factors compared between the two stocks.